Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection Academic Article uri icon

Overview

MeSH Major

  • HIV Infections
  • HIV-1
  • Nucleosides
  • Oxazines
  • Reverse Transcriptase Inhibitors

abstract

  • In this trial of the initial treatment of HIV-1 infection, the triple-nucleoside combination of abacavir, zidovudine, and lamivudine was virologically inferior to a regimen containing efavirenz and two or three nucleosides.

publication date

  • April 29, 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa031772

PubMed ID

  • 15115831

Additional Document Info

start page

  • 1850

end page

  • 61

volume

  • 350

number

  • 18